Allogeneic Therapy Segment Held Largest Share of South and Central America Cell therapy Market in 2019

According to our new market research study on “South and Central America Cell therapy Market to 2027 – Regional Analysis and Forecast – by ingredient type, indication, and forms,” the market is expected to reach US$ 415.8 million by 2027 from US$ 271.9 million in 2019; it is estimated to grow at a CAGR of 5.5% from 2020 to 2027. The report provides trends prevailing in the South and Central America Cell therapy market, and drivers and restraints pertaining to the market growth.  

The South and Central America Cell therapy market based on therapy type is segmented into Allogeneic, Autologous. In 2019, the allogeneic segment accounted for the largest share of the South and Central America Cell therapy market. The growth of the market for this segment is attributed to increasing Number of product launch to accelerate the overall product demand for stem therapy using allogeneic stem cell therapeutics. However, the autologous segment is likely register the highest CAGR in the market during the forecast period.   

The growth of the South and Central America Cell therapy market is mainly attributed to Increasing Prevalence of Chronic Diseases, Rising Adoption of Regenerative Medicines and Increasing Number of Approvals for Cell-Based Therapies. However, high costs of cell therapy manufacturing is the major factor hindering the market growth in South and Central America.

A few of the leading companies operating in the South and Central America Cell therapy market are NuVasive, Inc., Smith & Nephew, Bristol-Myers Squibb Company, Cells for Cells and others.

South and Central America Cell therapy Market, by Country, 2019 (%)

The report segments South and Central America Cell therapy market as follows:

South and Central America Cell therapy Market – By Therapy Type

• Allogeneic
• Autologous

South and Central America Cell therapy Market – By Product

• Consumables
• Equipment
• Systems and Software

South and Central America Cell therapy Market – By Technology

• Viral Vector Technology
• Genome Editing Technology
• Somatic Cell Technology
• Cell Immortalization Technology
• Cell Plasticity Technology
• Three-dimensional Technology

South and Central America Cell therapy Market – By Application

• Oncology
• Cardiovascular
• Orthopedic
• Wound Management
• Other Applications

South and Central America Cell therapy Market – By End user

• Research Institutes
• Hospitals
• Others

South and Central America Cell therapy Market – By Country

• South and Central America
  • Brazil
  • Argentina